Market Overview

Benzinga's Top Pre-Market Gainers

Related IRIS
UPDATE: Benchmark Downgrades IRIS International to Hold; Valuation at Takeover Price
Benzinga's M&A Chatter for Monday September 17, 2012
Related GNOM
Benzinga Market Primer: Wednesday, March 13
BGI-Shenzhen Receives Approval from Ministry of Commerce of PRC for Proposed Acquisition Of Complete Genomics

IRIS International (NASDAQ: IRIS) soared 43.44% to $19.25 in the pre-market trading. Danaher (NYSE: DHR) announced its plans to buy IRIS at a purchase price of $19.50 per share.

Complete Genomics (NASDAQ: GNOM) surged 13.86% to $3.04 in the pre-market session. Complete Genomics agreed to be bought by BGI-Shenzhen for $117.6 million.

Tesla Motors (NASDAQ: TSLA) added 8.59% to $33 in the pre-market session. Tesla Motors' trailing-twelve-month revenue is $153.86 million.

ACADIA Pharmaceuticals (NASDAQ: ACAD) moved up 5.66% to $2.24 in the pre-market session. ACADIA Pharmaceuticals shares have jumped 63.08% over the past 52 weeks, while the S&P 500 index has gained 20.54% in the same period.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (ACAD + DHR)

View Comments and Join the Discussion!

Partner Center